Acerta Pharma is a leader in the field of covalent binding technology who is applying this technology to create novel, highly selective therapies for cancer.

Pharmaceutical

Acerta Pharma B.V.

Acerta Pharma B.V.'s headquarters in Oss, Netherlands

Nico Stam

Jude Fitzgibbon

Martijn Bax

Anas Younes

Niko Andre

The Research and Development team at Acerta Pharma B.V. focuses on leveraging covalent binding technology to develop novel, highly selective therapies for cancer. This team of highly skilled scientists conducts advanced biological, bioinformatics, and translational research to identify and optimize breakthrough therapeutic compounds, aiming to improve patient outcomes in oncology.

Research and Development

The Clinical Operations Team at Acerta Pharma B.V. is responsible for planning, executing, and managing clinical trials to evaluate the efficacy and safety of novel cancer therapies developed using covalent binding technology. The team ensures regulatory compliance, oversees study logistics, and coordinates with global stakeholders to advance the company's oncology research programs.

Clinical Operations Team

The Research and Development team at Acerta Pharma B.V. focuses on pioneering advancements in covalent binding technology to develop innovative and highly selective cancer therapies. This team collaborates across various functions, including drug discovery, clinical operations, and biosciences, to identify and advance new therapeutic targets and bring groundbreaking hemato-oncology solutions from concept to clinical application.

Acerta Pharma B.V.

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations Team

Research and Development

Offices

Acerta Pharma B.V.

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations Team

Research and Development

Offices

Related companies